Latest Industry Projects

India's Mankind Pharma invests $16 Million in API unit, Rajasthan

India's Mankind Pharma invests $16 Million in API unit, Rajasthan

Introduction:

Indian drugmaker Mankind Pharma plans to build an API facility in northern India with an investment of $16 Million(Rs.100 crore).

Features:

This is basically a backward integration project largely for captive consumption and will have a capacity of 200 tonnes per annum.” The facility would focus on enabling the company to make cheaper drugs. The API facility is a step to promote affordable drug manufacturing in India where a third of the population has no access to medicines, Director Mr. Juneja said.

Specifications:

Company Name Mankind Pharma
Location Rajasthan, India
Type New API Facility
Estimated Cost $16 Million(Rs.100 crore)

 

mankindpharma.com

Other Projects